Nifty
Sensex
:
:
10029.10
33980.70
-32.45 (-0.32%)
-128.84 (-0.38%)

Pharmaceuticals & Drugs - Global

Rating :
75/99  (View)

BSE: 532331 | NSE: AJANTPHARM

1446.30
11.05 (0.77%)
04-Jun-2020 | 3:52PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1445.00
  •  1453.00
  •  1430.00
  •  1435.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  100815
  •  1458.09
  •  1580.00
  •  825.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,526.79
  • 26.78
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 12,462.24
  • 0.63%
  • 4.82

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.50%
  • 0.54%
  • 8.05%
  • FII
  • DII
  • Others
  • 8.91%
  • 10.44%
  • 1.56%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.52
  • 6.88
  • 1.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.84
  • 2.31
  • -3.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 27.53
  • 4.54
  • -8.60

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.70
  • 26.54
  • 22.45

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.46
  • 7.68
  • 4.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.55
  • 18.41
  • 15.35

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Net Sales
682
515
32%
651
485
34%
643
544
18%
612
511
20%
Expenses
531
388
37%
465
378
23%
465
378
23%
444
354
25%
EBITDA
151
127
19%
186
107
73%
178
166
7%
168
157
7%
EBIDTM
22%
25%
29%
22%
28%
31%
28%
31%
Other Income
57
2
3378%
15
4
232%
13
15
-13%
8
8
-6%
Interest
4
1
370%
2
0
1644%
5
0
3692%
2
0
953%
Depreciation
26
19
39%
24
19
26%
23
17
33%
23
17
33%
PBT
176
109
61%
175
93
88%
162
164
-1%
151
148
2%
Tax
47
20
130%
68
26
159%
45
38
18%
37
42
-13%
PAT
129
89
45%
108
67
61%
116
125
-7%
115
106
8%
PATM
19%
17%
17%
14%
18%
23%
19%
21%
EPS
14.79
10.18
45%
12.32
7.66
61%
13.33
14.36
-7%
13.13
12.12
8%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
2,588
2,055
2,126
1,983
1,734
1,474
1,208
931
677
499
409
Net Sales Growth
26%
-3%
7%
14%
18%
22%
30%
37%
36%
22%
 
Cost Of Goods Sold
656
296
317
323
317
290
284
250
188
153
140
Gross Profit
1,932
1,760
1,808
1,661
1,417
1,183
924
681
489
346
269
GP Margin
75%
86%
85%
84%
82%
80%
76%
73%
72%
69%
66%
Total Expenditure
1,905
1,489
1,467
1,296
1,147
968
840
706
545
409
331
Power & Fuel Cost
-
33
27
19
15
13
11
10
8
6
5
% Of Sales
-
2%
1%
1%
1%
1%
1%
1%
1%
1%
1%
Employee Cost
-
431
376
295
257
201
157
123
94
71
45
% Of Sales
-
21%
18%
15%
15%
14%
13%
13%
14%
14%
11%
Manufacturing Exp.
-
175
216
193
174
131
96
82
61
40
31
% Of Sales
-
8%
10%
10%
10%
9%
8%
9%
9%
8%
8%
General & Admin Exp.
-
146
132
92
66
51
47
37
34
25
23
% Of Sales
-
7%
6%
5%
4%
3%
4%
4%
5%
5%
6%
Selling & Distn. Exp.
-
321
306
271
246
234
202
170
131
91
78
% Of Sales
-
16%
14%
14%
14%
16%
17%
18%
19%
18%
19%
Miscellaneous Exp.
-
88
92
104
71
49
42
34
30
23
78
% Of Sales
-
4%
4%
5%
4%
3%
3%
4%
4%
5%
2%
EBITDA
683
566
658
687
587
505
369
224
132
90
79
EBITDA Margin
26%
28%
31%
35%
34%
34%
31%
24%
19%
18%
19%
Other Income
92
21
24
24
21
17
14
6
6
9
1
Interest
12
1
0
1
5
6
9
19
15
18
20
Depreciation
96
72
60
61
44
52
44
34
32
25
21
PBT
664
514
623
648
559
464
330
177
91
56
39
Tax
196
127
154
141
143
146
96
65
14
6
5
Tax Rate
30%
25%
25%
22%
26%
32%
29%
37%
15%
10%
12%
PAT
468
387
469
507
416
310
234
112
77
51
34
PAT before Minority Interest
468
387
469
507
416
310
234
112
77
51
34
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
18%
19%
22%
26%
24%
21%
19%
12%
11%
10%
8%
PAT Growth
21%
-17%
-8%
22%
34%
32%
109%
45%
52%
49%
 
EPS
53.57
44.33
53.68
58.06
47.61
35.49
26.79
12.84
8.85
5.81
3.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
2,245
2,041
1,568
1,191
841
593
393
298
229
185
Share Capital
18
18
18
18
18
18
12
12
12
12
Total Reserves
2,227
2,022
1,550
1,173
823
575
381
286
217
173
Non-Current Liabilities
42
39
9
29
56
81
102
101
76
233
Secured Loans
1
1
1
6
23
42
58
62
48
206
Unsecured Loans
0
0
0
9
10
11
16
14
11
22
Long Term Provisions
13
13
5
3
5
3
3
5
3
0
Current Liabilities
378
346
247
260
250
275
222
250
218
77
Trade Payables
225
250
178
146
109
125
132
101
71
69
Other Current Liabilities
94
64
46
57
58
48
19
43
30
0
Short Term Borrowings
33
0
0
46
18
61
51
95
109
0
Short Term Provisions
25
32
22
11
64
43
20
10
8
8
Total Liabilities
2,664
2,426
1,823
1,479
1,146
949
718
649
522
495
Net Block
1,179
1,053
589
451
288
279
273
246
214
168
Gross Block
1,610
1,417
895
716
550
492
438
378
313
243
Accumulated Depreciation
432
365
306
265
262
213
166
132
99
74
Non Current Assets
1,483
1,202
973
716
513
429
349
309
277
224
Capital Work in Progress
261
61
254
199
170
94
12
3
17
47
Non Current Investment
13
8
0
0
40
8
8
8
8
8
Long Term Loans & Adv.
28
77
42
21
9
39
49
51
34
0
Other Non Current Assets
3
4
2
4
5
9
7
1
3
0
Current Assets
1,181
1,224
851
763
633
520
369
340
246
271
Current Investments
65
182
182
77
19
55
0
0
0
0
Inventories
436
351
211
205
159
155
148
168
113
120
Sundry Debtors
459
460
323
372
259
202
150
141
104
97
Cash & Bank
101
93
70
43
137
60
46
11
12
15
Other Current Assets
121
115
9
7
59
47
25
19
17
40
Short Term Loans & Adv.
23
23
56
59
47
44
21
16
14
40
Net Current Assets
804
878
604
503
384
245
147
89
28
194
Total Assets
2,664
2,426
1,823
1,479
1,146
949
718
649
522
495

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
375
281
609
326
279
212
234
70
95
95
PBT
514
623
648
559
456
330
164
91
56
39
Adjustment
69
52
86
53
51
51
65
51
43
40
Changes in Working Capital
-90
-254
26
-124
-82
-75
39
-55
6
22
Cash after chg. in Working capital
493
421
760
488
426
306
267
88
105
100
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-118
-140
-151
-161
-146
-94
-33
-17
-10
-5
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-223
-256
-383
-209
-158
-188
-104
-53
-51
-43
Net Fixed Assets
-392
-327
-235
-197
-138
-121
-69
-46
-39
-42
Net Investments
118
-2
-105
-17
2
-60
-2
0
0
0
Others
52
73
-43
5
-23
-7
-33
-7
-12
-1
Cash from Financing Activity
-147
0
-202
-117
-105
-20
-104
-13
-56
-46
Net Cash Inflow / Outflow
5
25
24
0
16
4
26
4
-11
7
Opening Cash & Equivalents
91
66
41
42
39
34
8
4
15
8
Closing Cash & Equivalent
95
91
66
41
54
39
34
8
4
15

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
257
232
178
135
96
67
45
34
26
21
ROA
15%
22%
31%
32%
30%
28%
16%
13%
10%
7%
ROE
18%
26%
37%
41%
43%
47%
32%
29%
25%
20%
ROCE
24%
34%
46%
52%
56%
55%
39%
23%
18%
14%
Fixed Asset Turnover
1.36
1.84
2.49
2.76
2.85
2.61
2.29
1.98
1.81
1.90
Receivable days
82
67
63
66
57
53
57
65
73
87
Inventory Days
70
48
38
38
39
45
61
75
84
99
Payable days
63
57
50
42
46
59
62
60
68
66
Cash Conversion Cycle
88
58
51
62
49
39
56
80
89
120
Total Debt/Equity
0.02
0.00
0.00
0.07
0.09
0.22
0.32
0.67
0.83
1.23
Interest Cover
444
1,519
478
115
78
39
10
7
4
3

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.